Previous Article | Next Article ![]()
Infection and Immunity, March 2001, p. 1957-1960, Vol. 69, No. 3
Mikrobielle Genetik,1
and Physiologisch-chemisches Institut, Abteilung für
Physikalische Biochemie,2 Universität
Tübingen, Tübingen, Germany
Received 30 August 2000/Returned for modification 13 October
2000/Accepted 20 November 2000
Cross-inhibition by quorum-sensing pheromones between
Staphylococcus aureus and Staphylococcus
epidermidis was investigated using all known S. aureus
agr pheromone subgroups. All S. aureus subgroups were
sensitive towards the S. epidermidis pheromone, with the
exception of the recently identified subgroup 4. The subgroup 4 pheromone was also the only S. aureus pheromone able to
inhibit the S. epidermidis agr response. The close relation of subgroup 4 to subgroup 1 suggests that subgroup 4 might have evolved
from subgroup 1 by mutation under the selective pressure of competition
with S. epidermidis. The competition between S. aureus and S. epidermidis by means of quorum-sensing
cross talk seems to be generally in favor of S. epidermidis, which might explain the predominance of S. epidermidis on the skin and in infections on indwelling medical devices.
Quorum-sensing systems, which sense
and signal the state of cell density, are of high importance for the
survival of bacteria, as they enable them to respond to changing
environmental conditions (14). The agr system
of staphylococci is a quorum-sensing system which controls the
expression of exoproteins and surface proteins in a growth
phase-dependent manner (10). The extracellular
signal, which is used by the staphylococcal agr system, is a
small peptide pheromone that harbors an unusual posttranslational
modification (2). For Staphylococcus aureus and
Staphylococcus epidermidis, it has been shown that this
posttranslational modification is an intramolecular thioester, which
links the thiol group of a central cysteine to the C-terminal carboxy
group (5, 8). Interestingly, the primary sequence of the
pheromones of different species and also of different pheromone
subgroups within one species varies completely. Only the central
cysteine and its distance to the C terminus are conserved
(5, 8). For three S. aureus subgroups it has
been demonstrated that the corresponding pheromones can inhibit
the agr response of foreign subgroups (1). We
have shown that this is also the case between different
staphylococcal species, as the S. epidermidis pheromone has
proven to be an efficient inhibitor of the agr response of
S. aureus strain Newman (9). agr
controls the expression of several important virulence factors in
S. aureus, such as alpha-toxin, beta-toxin, delta-toxin,
serine protease, DNase, fibrinolysin, enterotoxin B, and toxic shock syndrome toxin 1 (12). Suppression of the agr
response in S. aureus by the above-mentioned pheromones also
suppresses the expression of various virulence factors in in vitro
studies (5, 9). Furthermore, the development of S. aureus-induced lesions in mice was efficiently suppressed when the
infecting strain was injected subcutaneously together with the
inhibiting pheromone of a foreign subgroup (5). Therefore,
agr pheromones and their derivatives have been proposed as
new antistaphylococcal drugs, especially in the treatment of infections
by S. aureus and S. epidermidis, which rank among
the most important pathogens in nosocomial infections (11).
S. aureus causes many acute severe infections, such as
impetigo, wound infections, or in toxic shock syndrome, whereas
chronic infections tend to be caused in a higher relative proportion by S. epidermidis (13). The prevalence of S. epidermidis in many nosocomial infections, among them infections
on indwelling medical devices, raises the question about the
advantage that S. epidermidis possesses in these
situations compared to S. aureus. Among the infections
predominantly caused by S. epidermidis one can often find
the involvement of biofilms (15), which constitute a
high-density population. This led us to the assumption that the more
frequent participation of S. epidermidis in these infections
might be due to interspecies concurrence based on cell density control
mechanisms. It has been proposed that the inhibiting properties of the
staphylococcal pheromones serve as weapons in a struggle between
different staphylococcal strains (1). To address the
question of interspecies concurrence, we added synthetic natural
S. epidermidis pheromone to S. aureus strains of
subgroups 1 to 4 and synthetic pheromones of S. aureus subgroups to S. epidermidis. S. aureus subgroup 4 has only
recently been discovered independently by us and by G. Lina (G. Lina,
personal communication). In a previous study, we investigated 15 S. epidermidis strains by sequencing the DNA coding for the
AgrD prepheromone and found only a single S. epidermidis
pheromone sequence, DSVCASYF (8), suggesting
that there is only one S. epidermidis agr pheromone group or
that this one is by far the most frequent. All pheromones and pheromone
derivatives were prepared by solid-phase synthesis as previously
described (8) and are shown in Fig.
1. The staphylococcal strains used were
S. epidermidis ATCC 14990, S. aureus strains A950227 (subgroup 1), A950085 (subgroup 2), A920226 (subgroup 3),
A970377 (subgroup 4), A970392 (subgroup 4), A850484 (subgroup 4), and
1527/97 (subgroup 4). All S. aureus strains are
clinical isolates. Strain 1527/97 was kindly provided by W. Witte, Robert-Koch Institut, Berlin, Germany, and classified as
subgroup 4 strain in our laboratory by DNA sequencing; the other
S. aureus strains were kindly provided by G. Lina, Centre
Hospitalier et Universitaire de Lyon, Lyon, France, and were classified
by G. Lina.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1957-1960.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Pheromone Cross-Inhibition between
Staphylococcus aureus and Staphylococcus
epidermidis
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (17K):
[in a new window]
FIG. 1.
Synthetic agr pheromone and derivatives used
in this study.
Inhibition of the agr system was monitored as we have previously described (7). Briefly, delta-toxin expression was determined by a high-performance liquid chromatography assay using a Pharmacia Resource PHE column and a water-acetonitrile gradient with 0.1% trifluoroacetic acid. Main cultures that were inoculated 1:100 from precultures were grown for 8 h, with pheromone addition at the time of inoculation. Afterwards, the samples were centrifuged and the supernatant was injected onto the column. Delta-toxin is encoded within the gene for the regulatory RNAIII, which is the intracellular effector of the agr system (6). Its expression is therefore a means to measure the activity of the agr system.
As shown in Fig. 2A, using pheromone
concentrations ranging from 25 nM to 1 µM, the synthetic peptide
corresponding to the natural S. epidermidis pheromone was
very active against S. aureus subgroup 3. It had
considerable activity against subgroups 1 and 2, but it was inactive
against subgroup 4. On the other hand, S. epidermidis was
insensitive to S. aureus pheromones from subgroups 1 to 3 and showed moderate sensitivity against S. aureus pheromone of subgroup 4 (Fig. 2B). This sensitivity was lower than that of the
S. aureus subgroups 1 to 3 towards the S. epidermidis pheromone. At the very high pheromone concentration of
10 µM, the S. epidermidis pheromone completely inhibited
delta-toxin expression in S. aureus subgroups 1, 2, and 3 but showed no effect on subgroup 4. At this concentration, the
pheromone of S. aureus subgroup 4 was able to entirely
suppress delta-toxin expression by S. epidermidis, whereas
the pheromones of S. aureus subgroups 1 to 3 still did not
show any inhibiting effect (data not shown).
|
These difference are most likely best explained by the more or less tight interaction of the pheromones with their receptor, the histidine kinase membrane enzyme AgrC. The third extracellular loop of this enzyme has been demonstrated to interact with the pheromone (4). It remains unclear if this interaction is a covalent one (by a trans-acylation reaction), as has been proposed (5). The charge of the pheromones does not correlate with the observed inhibiting properties, as the S. epidermidis pheromone and S. aureus pheromones of subgroups 1 and 3 have a net charge of zero, whereas the other tested pheromones harbor one positive charge. Therefore, other structural properties might be responsible for the differing interaction of the various pheromones with AgrC.
The most interesting result is the complete inactivity of the S. epidermidis pheromone against S. aureus subgroup 4 and the fact that only the pheromone of S. aureus subgroup 4 showed activity against S. epidermidis. We have tested three more subgroup 4 strains, which also proved to be completely insensitive to the S. epidermidis pheromone (data not shown).
Recently it has been observed that subgroup 4 strains are often involved in infections leading to scalded skin syndrome (G. Lina, personal communication). This means that these strains live on the skin, where they come into close contact and concurrence with S. epidermidis, which normally is the predominant strain on the skin (3). The subgroup 4 pheromone differs from that of subgroup 1 only by one amino acid (primary sequence YSTCYFIM instead of YSTCDFIM). It is therefore tempting to speculate that subgroup 4 might have evolved from subgroup 1 in order to be able to compete with S. epidermidis.
Activity of S. epidermidis pheromone derivatives
against S. aureus agr subgroups.
Among the
tested S. epidermidis pheromone derivatives are lactone and
lactam derivatives (derivatives 3 and 4) and derivatives with different
lengths of the N-terminal tail, adjacent to the thiolactone-bearing
ring structure (derivatives 1 and 2). Derivative 2 was slightly less
active than the natural pheromone against subgroups 1, 2, and 3. This
is in accordance with earlier data by which we could also show a
reduced activity against S. aureus Newman (9),
which belongs to subgroup 1. Derivative 1 exhibited an activity similar
to that of the natural pheromone against subgroups 1 and 3 but was less
active against subgroup 2. Both derivatives were inactive against
subgroup 4. The derivatives in which the thiolactone structure was
replaced by a lactone (derivative 3) or a lactam (derivative 4) showed
a slightly further reduced activity against all subgroups, as already
reported for subgroup 1 (9), but again no activity against
subgroup 4 (Fig. 3).
|
| |
ACKNOWLEDGMENTS |
|---|
We thank Vera Augsburger for excellent technical assistance and Gérard Lina and Wolfgang Witte for providing S. aureus subgroup strains.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Mikrobielle Genetik, Universität Tübingen, Waldhäuserstr. 70/8, D-72076 Tübingen, Germany. Phone: 49-7071-2975938. Fax: 49-7071-295937. E-mail: michael.otto{at}uni-tuebingen.de.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ji, G.,
R. Beavis, and R. P. Novick.
1997.
Bacterial interference caused by autoinducing peptide variants.
Science
276:2027-2030 |
| 2. |
Ji, G.,
R. C. Beavis, and R. P. Novick.
1995.
Cell density control of staphylococcal virulence mediated by an octapeptide pheromone.
Proc. Natl. Acad. Sci. USA
92:12055-12059 |
| 3. | Kloos, W. E., K.-H. Schleifer, and F. Götz. 1992. The genus Staphylococcus, p. 1369-1420. In A. Balows, H. G. Trüper, M. Dworkin, W. Harder, and K.-H. Schleifer (ed.), The prokaryotes, a handbook on the biology of bacteria: ecophysiology, isolation, identification, application, 2nd ed., vol. II. Springer-Verlag, New York, N.Y. |
| 4. | Lina, G., S. Jarraud, G. Ji, T. Greenland, A. Pedraza, J. Etienne, R. P. Novick, and F. Vandenesch. 1998. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol. Microbiol. 28:655-662[CrossRef][Medline]. |
| 5. |
Mayville, P.,
G. Ji,
R. Beavis,
H. Yang,
M. Goger,
R. P. Novick, and T. W. Muir.
1999.
Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence.
Proc. Natl. Acad. Sci. USA
96:1218-1223 |
| 6. | Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975[Medline]. |
| 7. | Otto, M., and F. Götz. 2000. Analysis of quorum sensing activity in staphylococci by RP-HPLC of staphylococcal delta-toxin. BioTechniques 28:1088-1090[Medline], 1092, 1096. |
| 8. | Otto, M., R. Süssmuth, G. Jung, and F. Götz. 1998. Structure of the pheromone peptide of the Staphylococcus epidermidis agr system. FEBS Lett. 424:89-94[CrossRef][Medline]. |
| 9. | Otto, M., R. Süssmuth, C. Vuong, G. Jung, and F. Götz. 1999. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett. 450:257-262[CrossRef][Medline]. |
| 10. |
Peng, H. L.,
R. P. Novick,
B. Kreiswirth,
J. Kornblum, and P. Schlievert.
1988.
Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus.
J. Bacteriol.
170:4365-4372 |
| 11. | Raad, I., A. Alrahwan, and K. Rolston. 1998. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin. Infect. Dis. 26:1182-1187[Medline]. |
| 12. | Recsei, P., B. Kreiswirth, M. O'Reilly, P. Schlievert, A. Gruss, and R. P. Novick. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol. Gen. Genet. 202:58-61[CrossRef][Medline]. |
| 13. | Rupp, M. E., and G. D. Archer. 1994. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19:231-245[Medline]. |
| 14. | Swift, S., J. P. Throup, P. Williams, G. P. C. Salmond, and G. S. A. B. Stewart. 1996. Quorum sensing: a population-density component in the determination of bacterial phenotype. Trends Biochem. Sci. 21:214-219[CrossRef][Medline]. |
| 15. | von Eiff, C., C. Heilmann, M. Herrmann, and G. Peters. 1999. Basic aspects of the pathogenesis of staphylococcal polymer-associated infections. Infection 27(Suppl. 1):7-10. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»